Brechbiel M - Search Results

1

Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.

Wu C, Jagoda E, Brechbiel M, Webber KO, Pastan I, Gansow O, Eckelman WC. Wu C, et al. Among authors: brechbiel m. Bioconjug Chem. 1997 May-Jun;8(3):365-9. doi: 10.1021/bc970032k. Bioconjug Chem. 1997. PMID: 9177842

2

Synthesis of 2-(p-thiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid: application of the 4-methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines.

McMurry TJ, Brechbiel M, Wu C, Gansow OA. McMurry TJ, et al. Among authors: brechbiel m. Bioconjug Chem. 1993 May-Jun;4(3):236-45. doi: 10.1021/bc00021a009. Bioconjug Chem. 1993. PMID: 8324015

3

Backbone-substituted DTPA ligands for 90Y radioimmunotherapy.

Brechbiel MW, Gansow OA. Brechbiel MW, et al. Bioconjug Chem. 1991 May-Jun;2(3):187-94. doi: 10.1021/bc00009a008. Bioconjug Chem. 1991. PMID: 1932218

4

Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin.

Mirzadeh S, Brechbiel MW, Atcher RW, Gansow OA. Mirzadeh S, et al. Among authors: brechbiel mw. Bioconjug Chem. 1990 Jan-Feb;1(1):59-65. doi: 10.1021/bc00001a007. Bioconjug Chem. 1990. PMID: 2095205

5

Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins.

Lang L, Jagoda E, Wu C, Brechbiel MW, Gansow OA, Pastan I, Paik CH, Carrasquillo JA, Eckelman WC. Lang L, et al. Among authors: brechbiel mw. Q J Nucl Med. 1997 Jun;41(2):53-61. Q J Nucl Med. 1997. PMID: 9203844

6

Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.

Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW. Kobayashi H, et al. Among authors: brechbiel mw. Bioconjug Chem. 1999 Jan-Feb;10(1):103-11. doi: 10.1021/bc980091d. Bioconjug Chem. 1999. PMID: 9893971

7

Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.

Wesley JN, McGee EC, Garmestani K, Brechbiel MW, Yordanov AT, Wu C, Gansow OA, Eckelman WC, Bacher JD, Flynn M, Goldman CK, MacLin M, Schwartz UP, Jackson-White T, Phillip CM, Decker J, Waldmann TA. Wesley JN, et al. Among authors: brechbiel mw. Nucl Med Biol. 2004 Apr;31(3):357-64. doi: 10.1016/j.nucmedbio.2003.08.011. Nucl Med Biol. 2004. PMID: 15028248

8

Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.

Yao Z, Zhang M, Garmestani K, Axworthy DB, Mallett RW, Fritzberg AR, Theodore LJ, Plascjak PS, Eckelman WC, Waldmann TA, Pastan I, Paik CH, Brechbiel MW, Carrasquillo JA. Yao Z, et al. Among authors: brechbiel mw. Clin Cancer Res. 2004 May 1;10(9):3137-46. doi: 10.1158/1078-0432.ccr-03-0171. Clin Cancer Res. 2004. PMID: 15131055

9

Convenient synthesis of bifunctional tetraaza macrocycles.

McMurry TJ, Brechbiel M, Kumar K, Gansow OA. McMurry TJ, et al. Among authors: brechbiel m. Bioconjug Chem. 1992 Mar-Apr;3(2):108-17. doi: 10.1021/bc00014a004. Bioconjug Chem. 1992. PMID: 1515464

10

Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.

Horak E, Hartmann F, Garmestani K, Wu C, Brechbiel M, Gansow OA, Landolfi NF, Waldmann TA. Horak E, et al. Among authors: brechbiel m. J Nucl Med. 1997 Dec;38(12):1944-50. J Nucl Med. 1997. PMID: 9430475 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters